Literature DB >> 17337474

Anti-tumour necrosis factor alpha therapy in patients with impaired renal function.

Axel J Hueber, Andac Tunc, Georg Schett, Bernhard Manger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17337474      PMCID： PMC1955094          DOI： 10.1136/ard.2006.069211

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  8 in total

Review 1.  Tumour necrosis factor inhibitors: risks and benefits in patients with rheumatoid arthritis.

Authors:  L Roberts; G J McColl
Journal:  Intern Med J       Date:  2004-12       Impact factor: 2.048

2.  Infliximab and nephrotic syndrome.

Authors:  George Chin; Grant Luxton; Jennet M Harvey
Journal:  Nephrol Dial Transplant       Date:  2005-10-04       Impact factor: 5.992

3.  Infliximab treatment in a patient with rheumatoid arthritis on hemodialysis.

Authors:  Ranju Singh; Raquel Cuchacovich; Wenqun Huang; Luis R Espinoza
Journal:  J Rheumatol       Date:  2002-03       Impact factor: 4.666

Review 4.  Adverse reactions to biologic agents: focus on autoimmune disease therapies.

Authors:  Susan J Lee; Arthur Kavanaugh
Journal:  J Allergy Clin Immunol       Date:  2005-10       Impact factor: 10.793

5.  Infliximab therapy in established rheumatoid arthritis: an observational study.

Authors:  Paraskevi V Voulgari; Yannis Alamanos; Spyros N Nikas; Dimitrios V Bougias; Themistoklis I Temekonidis; Alexandros A Drosos
Journal:  Am J Med       Date:  2005-05       Impact factor: 4.965

6.  Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis.

Authors:  Michael B Stokes; Kirk Foster; Glen S Markowitz; Farhang Ebrahimi; William Hines; Darren Kaufman; Brooke Moore; Daniel Wolde; Vivette D D'Agati
Journal:  Nephrol Dial Transplant       Date:  2005-04-19       Impact factor: 5.992

7.  Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy.

Authors:  Jacques-Eric Gottenberg; Florence Merle-Vincent; Fabrice Bentaberry; Yannick Allanore; Francis Berenbaum; Bruno Fautrel; Bernard Combe; Antoine Durbach; Jean Sibilia; Maxime Dougados; Xavier Mariette
Journal:  Arthritis Rheum       Date:  2003-07

8.  Nephrotic syndrome as a complication of anti-TNFalpha in a patient with rheumatoid arthritis.

Authors:  A A den Broeder; K J M Assmann; P L C M van Riel; J F M Wetzels
Journal:  Neth J Med       Date:  2003-04       Impact factor: 1.422
  8 in total
  7 in total

Review 1.  Methotrexate for rheumatoid arthritis patients who are on hemodialysis.

Authors:  Hasanein Al-Hasani; Euthalia Roussou
Journal:  Rheumatol Int       Date:  2011-07-22       Impact factor: 2.631

2.  Effect of anti-tumor necrosis factor alpha treatment of rheumatoid arthritis and chronic kidney disease.

Authors:  Hyun Woo Kim; Chang-Keun Lee; Hoon-Suk Cha; Jung-Yoon Choe; Eun-Jung Park; Jinseok Kim
Journal:  Rheumatol Int       Date:  2014-10-08       Impact factor: 2.631

Review 3.  A case report of a psoriatic arthritis patient on hemodialysis treated with tumor necrosis factor blocking agent and a literature review.

Authors:  Ioanna Saougou; Charalampos Papagoras; Theodora E Markatseli; Paraskevi V Voulgari; Alexandros A Drosos
Journal:  Clin Rheumatol       Date:  2010-05-21       Impact factor: 2.980

4.  Effect of tumor necrosis factor inhibitors on risk of cardiovascular disease in patients with axial spondyloarthritis.

Authors:  Oh Chan Kwon; Min-Chan Park
Journal:  Arthritis Res Ther       Date:  2022-06-13       Impact factor: 5.606

Review 5.  Psoriatic Arthritis: The Influence of Co-morbidities on Drug Choice.

Authors:  Sneha Patel; Anand Kumthekar
Journal:  Rheumatol Ther       Date:  2021-11-19

Review 6.  Role of Macrophages and Related Cytokines in Kidney Disease.

Authors:  Elena Cantero-Navarro; Sandra Rayego-Mateos; Macarena Orejudo; Lucía Tejedor-Santamaria; Antonio Tejera-Muñoz; Ana Belén Sanz; Laura Marquez-Exposito; Vanessa Marchant; Laura Santos-Sanchez; Jesús Egido; Alberto Ortiz; Teresa Bellon; Raúl R Rodrigues-Diez; Marta Ruiz-Ortega
Journal:  Front Med (Lausanne)       Date:  2021-07-08

7.  Gender Is a Risk Factor for Annual Decline in Estimated Glomerular Filtration Rate in Patients Treated with Biological DMARDs in Rheumatoid Arthritis and Ankylosing Spondylitis: a Retrospective Observational Study.

Authors:  Seong-Kyu Kim; Jung-Yoon Choe
Journal:  J Korean Med Sci       Date:  2018-05-28       Impact factor: 2.153
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.